Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
ingenol mebutate
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
D06BX21
|
| gptkbp:form |
gel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Picato
|
| gptkbp:legalStatus |
withdrawn
|
| gptkbp:manufacturer |
gptkb:LEO_Pharma
|
| gptkbp:retired |
safety concerns
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
skin irritation
swelling erythema blistering pain at application site |
| gptkbp:usedFor |
gptkb:actinic_keratosis
|
| gptkbp:withdrawn |
2020
|
| gptkbp:bfsParent |
gptkb:LEO_Pharma
|
| gptkbp:bfsLayer |
7
|